BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 12, 2016
View Archived Issues
Kymab and MD Anderson form immuno-oncology R&D alliance
Read More
Jubilant Biosys and Sanofi Deutschland collaborate in metabolic disorders
Read More
Memorial Sloan Kettering and Juno Therapeutics sign licensing agreement for MUC-16 binder
Read More
Dual Therapeutics and Bristol-Myers Squibb establish collaboration in cancer
Read More
Illumina launches cancer diagnostic company GRAIL
Read More
Pfizer announces investments and a research collaboration
Read More
Diffusion Pharmaceuticals completes merger with RestorGenex
Read More
FDA grants fast track designation for GC-4419
Read More
Adenoviral GDEPT combined with radiotherapy safe and effective in phase II prostate cancer study
Read More
Tobira Therapeutics initiates a program to evaluate cenicriviroc for the treatment of PSC
Read More
FDA grants orphan drug designation for WT1 cancer vaccine for the treatment of AML
Read More
Innate Pharma signs new licensing agreements with Orega, Sanofi
Read More
Mylan to codevelop six Momenta biosimilars
Read More
Medshine Discovery patents PI3Kalpha inhibitors
Read More
Cisen Pharmaceutical and Medshine Discovery report mTOR/PI3Kalpha inhibitors
Read More
Researchers attempt to find tools for early diagnosis of pancreatic cancer
Read More
Shire and Baxalta to combine
Read More
High-dose monovalent inactivated poliovirus type 2 vaccine is safe and immunogenic in infants
Read More
Theravance changes name to Innoviva
Read More
Exelixis files MAA for cabozantinib in RCC
Read More
Topical quinolone antibacterial Zebiax launched in Japan
Read More
Protagonist Therapeutics begins phase I study of PTG-100
Read More
Zogenix initiates first phase III trial of ZX-008 for Dravet syndrome
Read More
Merck KGaA agrees terms to return evofosfamide rights to Threshold Pharmaceuticals
Read More
Archexin in combination with everolimus shows promise for RCC
Read More
MabTech completes Chinese phase III trials for biosimilars STI-001 and STI-002
Read More
